Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will Facebook Inc (FB) Continue to Plummet?

Page 1 of 2

Many short-term traders have made nice profits from Facebook Inc (NASDAQ:FB) thanks to the wild swings in its stock price. However, most long-term investors have been disappointed. Facebook IPO’d at $38, but it’s now trading at just $24. To make matters worse, this performance came during a time when the broader market continued its relentless ascent. Has the stock now been hit hard enough to make Facebook an attractive investment?

Facebook Inc (NASDAQ:FB)

On the surface, this wouldn’t appear to be the case. Facebook Inc (NASDAQ:FB) is currently trading at 514 times trailing earnings and 31 times forward earnings. In other words, it’s still expensive, especially considering it only sports a profit margin of 1.22%.

Just to give you an idea of how unattractive Facebook is compared to one of its peers, Google Inc (NASDAQ:GOOG) is trading at 26 times trailing earnings, 16 times forward earnings, and it has a profit margin of 20.92%. It might already seem like Facebook Inc (NASDAQ:FB) should be discounted as an investment option. But there’s more to the story here.

Facebook’s improved earnings and revenue

Facebook’s stock is down 9.73% year to date, but three of the last five quarters have been profitable, including the last two quarters.

You might be thinking that many companies throughout the broader market have been improving their bottom lines due to cost-cutting. But Facebook Inc (NASDAQ:FB) has also consistently improved its revenue on an annual basis.

Furthermore, revenue improved last quarter by 37.80% year over year. A lot of this has had to do with Facebook’s mobile ad revenue, which now accounts for 30% of total revenue. Thanks to the increasing popularity of smartphones and tablets, Facebook’s mobile ad revenue should continue to grow.

Facebook’s improved traffic

Wasn’t Facebook Inc (NASDAQ:FB) getting stale? Wasn’t the younger generation opting for other social networking platforms? Unfortunately for Facebook, the latter might be true.

Younger audiences always want something new, because it represents their generation. Once a website becomes mainstream, it loses its “cool” identity.  The most over-represented age group on Facebook is 65+. However, despite many younger people moving to other social networking platforms, Facebook Inc (NASDAQ:FB) has one again overtaken Google Inc (NASDAQ:GOOG) as the most visited website in the world.

That’s right. According to, Facebook is ranked No. 1 in the world and No. 2 in the United States. Those numbers are reversed for Google Inc (NASDAQ:GOOG) — it’s ranked No. 2 in the world and No. 1 in the United States. As long as Facebook remains the most visited or second-most visited site in the world, its monetization opportunities are phenomenal.

The most over-represented education group on Facebook Inc (NASDAQ:FB) is Graduate School, compared to College, Some College, or No College. According to the United States Census Bureau, the average annual salary for people with a master’s degree is $55,242 — 30% higher than the average annual salary for people with a bachelor’s degree, and 70% higher than the average annual salary for people without a college degree. Therefore, Facebook’s monetization opportunities are good.

As far as Facebook’s traffic for the past three months, users are viewing fewer pages per visit, but spending 11% more time on the site. It’s evident that Facebook Inc (NASDAQ:FB)’s content is interesting enough to keep people on the page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!